Meningococcal Vaccines Global Market Report 2026

Description

Meningococcal vaccinations are designed to protect against Neisseria meningitidis, the bacteria that cause meningitis and bloodstream infections. These vaccines enable the immune system to recognize and combat the bacteria before illness develops. They are primarily used to prevent severe, potentially life-threatening meningococcal disease, particularly in high-risk groups such as adolescents, college students, and travelers.

The main types of meningococcal vaccines include meningococcal conjugate vaccines, polysaccharide vaccines, and subcapsular vaccines. Meningococcal conjugate vaccines consist of a polysaccharide antigen linked (conjugated) to a carrier molecule. The vaccines cover different serotypes, including Men ACWY, Men B/Bc, and Men C, and are administered to various age groups such as infants, children, adolescents, young adults, and adults. These vaccines are distributed through pharmacies, community clinics, public health agencies, and other channels, and are used by hospitals, research institutions, and academic centers.

Tariffs have influenced the meningococcal vaccines market by increasing the cost of imported vaccine components and raw materials, leading to higher production expenses. This impact is most pronounced in regions such as Asia-Pacific and Europe, where large volumes of vaccines and biologics are manufactured and distributed. Segments like meningococcal conjugate vaccines and polysaccharide vaccines face significant cost pressures, while public health programs may experience delays in procurement. However, tariffs have also encouraged local manufacturing initiatives and supply chain diversification, which could foster long-term market resilience and innovation.

The meningococcal vaccines market research report is one of a series of new reports from The Business Research Company that provides meningococcal vaccines market statistics, including meningococcal vaccines industry global market size, regional shares, competitors with a meningococcal vaccines market share, detailed meningococcal vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the meningococcal vaccines industry. This meningococcal vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The meningococcal vaccines market size has grown strongly in recent years. It will grow from $4.26 billion in 2025 to $4.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to introduction of meningococcal conjugate vaccines, rising incidence of meningitis outbreaks, government immunization campaigns, growing pediatric vaccination coverage, increased public health funding.

The meningococcal vaccines market size is expected to see strong growth in the next few years. It will grow to $6.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in vaccine technology, expansion of global immunization programs, increasing awareness of meningococcal disease, strategic partnerships and collaborations, growth in adolescent and young adult vaccination initiatives. Major trends in the forecast period include expansion of pediatric vaccination programs, development of broad-spectrum meningococcal vaccines, increased government immunization initiatives, rising awareness of meningococcal disease prevention, growth of school and college vaccination campaigns.

Rising healthcare spending is expected to drive growth in the meningococcal vaccine market in the coming years. Healthcare encompasses residential care institutions, nursing facilities, and intermediate care centers for individuals with mental illnesses or intellectual disabilities. The higher cost of newer vaccine generations compared to older ones has raised discussions on whether the benefits justify the prices, making it increasingly important to assess the full social and economic advantages of vaccination. For instance, in April 2025, according to an article published by the American Medical Association, a US-based professional association, health spending in the U.S. increased by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita-a significant rise from the 4.6% increase in 2022. Therefore, rising healthcare expenditure is fueling the growth of the meningococcal vaccine market.

Leading companies in the meningococcal vaccine market are developing new vaccines that provide protection against multiple serogroups to enhance market profitability. Meningococcal vaccines are designed to prevent infections caused by specific serogroups of the bacterium Neisseria meningitidis. For example, in October 2023, Pfizer Inc., a US-based pharmaceutical company, received FDA approval for PENBRAYA. This vaccine provides extensive serogroup coverage, protecting against groups A, B, C, W, and Y. FDA approval was based on robust Phase 2 and 3 trial data, demonstrating non-inferior immunogenicity compared to Trumenba + Menveo across all serogroups, alongside a favorable safety profile. In September 2022, Pfizer announced positive outcomes from a Phase 3 trial comparing PENBRAYA with existing licensed meningococcal vaccines in terms of safety, tolerability, and immunogenicity.

In September 2023, Biovac Institute, a South Africa-based vaccine manufacturer, partnered with EuBiologics Co., Ltd., to facilitate technology transfer for meningitis vaccines. The collaboration aims to strengthen local production capabilities, improve access to high-quality meningitis vaccines, and support regional immunization programs while fostering innovation and growth in vaccine development. EuBiologics Co., Ltd. is a South Korea-based biopharmaceutical company specializing in research, development, and commercialization of vaccines for infectious diseases.

Major companies operating in the meningococcal vaccines market are Pfizer Inc.,GlaxoSmithKline plc,Sanofi Pasteur,Merck & Co. Inc.,Serum Institute of India Pvt. Ltd.,Bio-Manguinhos,Walvax Biotechnology Co. Ltd.,Bharat Biotech,Panacea Biotec Ltd.,CSL Limited,Minhai Biotechnology Co. Ltd.,Hualan Biological Engineering Inc.,Shenzhen Kangtai Biological Products Co. Ltd.,Chongqing Zhifei Biological Products Co. Ltd.,Incepta Pharmaceuticals Ltd.,Biological E. Limited,Biokangtai,Biomed Pvt Ltd.,Biocine SCL,Bavarian Nordic A/S

North America was the largest region in the meningococcal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the meningococcal vaccines market report during the forecast period. The regions covered in the meningococcal vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the meningococcal vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The meningococcal vaccines market consists of sales of conjugate vaccines, combination vaccines, serogroup B vaccine products, and other types. Values in this market are 'pharmaceuticals' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Meningococcal Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses meningococcal vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for meningococcal vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The meningococcal vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Vaccine Type: Meningococcal Conjugate Vaccine; Polysaccharide; Subcapsular Vaccine
2) By Serotype: Men Acwy; Men B/Bc; Men C
3) By Age Group: Infants; Children; Adolescents and Young Adults; Adults
4) By Distribution Channel: Pharmacies; Community Clinics; Public Health Agencies; Other Channels
5) By End user: Hospitals; Research; Academic Institutes
Subsegments:
1) By Meningococcal Conjugate Vaccine: Quadrivalent Conjugate Vaccine (MenACWY); Bivalent Conjugate Vaccine
2) By Polysaccharide Vaccine: Meningococcal Polysaccharide Vaccine (MPSV4); Group C Polysaccharide Vaccine
3) By Subcapsular Vaccine: Meningococcal B Vaccine (MenB); Combination Subcapsular Vaccines
Companies Mentioned: Pfizer Inc.;GlaxoSmithKline plc;Sanofi Pasteur;Merck & Co. Inc.;Serum Institute of India Pvt. Ltd.;Bio-Manguinhos;Walvax Biotechnology Co. Ltd.;Bharat Biotech;Panacea Biotec Ltd.;CSL Limited;Minhai Biotechnology Co. Ltd.;Hualan Biological Engineering Inc.;Shenzhen Kangtai Biological Products Co. Ltd.;Chongqing Zhifei Biological Products Co. Ltd.;Incepta Pharmaceuticals Ltd.;Biological E. Limited;Biokangtai;Biomed Pvt Ltd.;Biocine SCL;Bavarian Nordic A/S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH6MMVAC01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Meningococcal Vaccines Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Meningococcal Vaccines Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Meningococcal Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Meningococcal Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.4 Sustainability, Climate Tech & Circular Economy
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Expansion Of Pediatric Vaccination Programs
- 4.2.2 Development Of Broad-Spectrum Meningococcal Vaccines
- 4.2.3 Increased Government Immunization Initiatives
- 4.2.4 Rising Awareness Of Meningococcal Disease Prevention
- 4.2.5 Growth Of School And College Vaccination Campaigns

5. Meningococcal Vaccines Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Research Institutes
5.3 Academic Institutes
5.4 Public Health Agencies
5.5 Pharmacies

6. Meningococcal Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Meningococcal Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Meningococcal Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Meningococcal Vaccines Market Size, Comparisons And Growth Rate Analysis
7.3. Global Meningococcal Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Meningococcal Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Meningococcal Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Meningococcal Vaccines Market Segmentation

9.1. Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
9.2. Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Men Acwy, Men B/Bc, Men C
9.3. Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Infants, Children, Adolescents and Young Adults, Adults
9.4. Global Meningococcal Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmacies, Community Clinics, Public Health Agencies, Other Channels
9.5. Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Research, Academic Institutes
9.6. Global Meningococcal Vaccines Market, Sub-Segmentation Of Meningococcal Conjugate Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine
9.7. Global Meningococcal Vaccines Market, Sub-Segmentation Of Polysaccharide Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine
9.8. Global Meningococcal Vaccines Market, Sub-Segmentation Of Subcapsular Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines

10. Meningococcal Vaccines Market Regional And Country Analysis

10.1. Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Meningococcal Vaccines Market

11.1. Asia-Pacific Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Meningococcal Vaccines Market

12.1. China Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Meningococcal Vaccines Market

13.1. India Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Meningococcal Vaccines Market

14.1. Japan Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Meningococcal Vaccines Market

15.1. Australia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Meningococcal Vaccines Market

16.1. Indonesia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Meningococcal Vaccines Market

17.1. South Korea Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Meningococcal Vaccines Market

18.1. Taiwan Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Meningococcal Vaccines Market

19.1. South East Asia Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Meningococcal Vaccines Market

20.1. Western Europe Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Meningococcal Vaccines Market

21.1. UK Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Meningococcal Vaccines Market

22.1. Germany Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Meningococcal Vaccines Market

23.1. France Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Meningococcal Vaccines Market

24.1. Italy Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Meningococcal Vaccines Market

25.1. Spain Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Meningococcal Vaccines Market

26.1. Eastern Europe Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Meningococcal Vaccines Market

27.1. Russia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Meningococcal Vaccines Market

28.1. North America Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Meningococcal Vaccines Market

29.1. USA Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Meningococcal Vaccines Market

30.1. Canada Meningococcal Vaccines Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Meningococcal Vaccines Market

31.1. South America Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Meningococcal Vaccines Market

32.1. Brazil Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Meningococcal Vaccines Market

33.1. Middle East Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Meningococcal Vaccines Market

34.1. Africa Meningococcal Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Meningococcal Vaccines Market Regulatory and Investment Landscape

36. Meningococcal Vaccines Market Competitive Landscape And Company Profiles

36.1. Meningococcal Vaccines Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Meningococcal Vaccines Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Meningococcal Vaccines Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Meningococcal Vaccines Market Other Major And Innovative Companies

Bio-Manguinhos, Walvax Biotechnology Co. Ltd., Bharat Biotech, Panacea Biotec Ltd., CSL Limited, Minhai Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Incepta Pharmaceuticals Ltd., Biological E. Limited, Biokangtai, Biomed Pvt Ltd., Biocine SCL, Bavarian Nordic A/S

38. Global Meningococcal Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Meningococcal Vaccines Market

40. Meningococcal Vaccines Market High Potential Countries, Segments and Strategies

40.1 Meningococcal Vaccines Market In 2030 - Countries Offering Most New Opportunities
40.2 Meningococcal Vaccines Market In 2030 - Segments Offering Most New Opportunities
40.3 Meningococcal Vaccines Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer